Table 2 Patient characteristics based on COVID-19 mortality
Author | Country (City) | Study design | Study period | Survived | Died | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | BMI (kg/m2) | Dyslipidemia (n) | Non-dyslipidemia (n) | Age (years) | BMI (kg/m2) | Dyslipidemia (n) | Non-dyslipidemia (n) | ||||
Almazeedi[13] | Kuwait | Cohort | Feb24–Apr20, 2020 | 38.7 ± 15.1 | 26.8 ± 5.9 | 62 | 1015 | 55.0 ± 10.1 | 33 ± 4.7 | 3 | 16 |
Khalil[27] | UK(London) | Cohort | Mar7–Apr7, 2020 | 63.8 (61.1–66.4) | NA | 34 | 128 | 75.8 (72.5–79.2) | NA | 16 | 42 |
Gayam[28] | USA(New York) | Cohort | Mar1–Apr9, 2020 | 63 [53–73] | 28.3 [25.0–33.6] | 41 | 235 | 71 [62–80] | 31.8 [26.5–37] | 25 | 107 |
Goicoechea[29] | Spain | Cohort | Mar12–Apr10, 2020 | 69 ± 14 | 27.2 ± 4.5 | 18 | 7 | 75 ± 6 | 25.1 ± 3.6 | 6 | 5 |
Santos[30] | Spain (Leon) | Cohort | Mar1–Jun1, 2020 | 75.1 [69.3–75.8] | NA | 12 | 16 | 78.4 [74.5–83.5] | NA | 9 | 1 |
Wang[31] | USA (New York) | Cohort | Mar1–Apr30, 2020 | 71 [18.5] | 28.2 [10.2] | 13 | 9 | 68 [8] | 29.5 [9.9] | 12 | 2 |
Ferrando[32] | Spain | Cohort | Mar12–May16, 2020 | 62 [53–71] | 28.6 [25.7–32.4] | 55 | 405 | 68 [62–73] | 27.7 [25.3–31.6] | 35 | 168 |
Zhang[19] | China (Beijing) | Cohort | Jan–Feb, 2020 | NA | NA | 2 | 75 | 84.00 ± 8.185 | NA | 1 | 2 |
Hwang[33] | South Korea (Daegu) | Cohort | Feb1–Mar25, 2020 | 64.62 ± 15.84 | NA | 10 | 67 | 76.50 ± 9.25 | NA | 3 | 23 |
Smith[34] | New England | Cohort | Mar1–Apr22, 2020 | 63.56 | 30.94 | 107 | 122 | 73.31 | 29.85 | 60 | 57 |
Grasselli[35] | Italy (Milan) | Cohort | Feb20–Apr22, 2020 | NA | NA | 169 | 1893 | NA | NA | 376 | 1550 |